Skip to the main content

Review article

The new therapeutic options in the treatment of rheumatoid arthritis

Porin PERIĆ ; Clinic for Rheumatic Diseases and Rehabilitation Clinical Hospital Centar Zagreb, Kišpatićeva 12, Zagreb


Full text: croatian pdf 155 Kb

page 23-39

downloads: 423

cite

Full text: english pdf 155 Kb

page 23-39

downloads: 465

cite


Abstract

Rheumatoid arthritis(RA) is a chronic, inflammatory, autoimmune disease wich affects approximately 1% of world population. Multiple cytokines operate as a network in a redundant and overlapping manner in rheumatoid artrhitis. This review highlights recent data on tumor-necrosis factor alpha (TNF-alfa), interleukin-1 inhibitors, as well as new biological agents abatacept and rituximab wich are specifically targeted
to T cells and to population of B cells.

Keywords

biological agents; rheumatoid arthritis; TNF-alpha inhibitors

Hrčak ID:

129200

URI

https://hrcak.srce.hr/129200

Publication date:

28.7.2006.

Article data in other languages: croatian

Visits: 2.476 *